Henry Schein, Inc. (H1SI34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 233.22 |
|---|---|
| 52-week range | 190.76 – 245.84 |
| Return, 1 month / 3 months | +0.0% / +22.3% |
| Return, 1 year / 3 years | +22.3% / +23.1% |
| Trend | Uptrend |
| RSI (14) | 88 |
| Volatility (1 year) | 20.5% |
| Worst drawdown (1 year) | -2.0% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Henry Schein is a distributor of healthcare products and services, based in the United States. It supplies dental practices with consumables, equipment and practice-management support, and serves medical practitioners such as physicians and veterinarians through its medical and animal health businesses. Its customers are mainly office-based healthcare professionals and the organisations that support them, and it also offers related technology and value-added services that help these practices run their day-to-day operations.
Henry Schein, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code H1SI34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Henry Schein, Inc. (H1SI34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 233.22 on 15 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 68 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.3% and over the last three months it rose 22.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.4% | ||
| From 52-week high | -0.7% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 22.3% | ||
| 6-month return | 22.3% | ||
| 12-month return, skipping the last month | 22.3% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -2.0% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 91.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +22.3% |
| 6 months | +22.3% |
| 1 year | +22.3% |
| 3 years | +23.1% |
| 5 years | +6.0% |
Signals
| 50-day / 200-day average | 222.15 / 198.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.